Literature DB >> 16710840

Vaccinia virus proteolysis--a review.

Chelsea M Byrd1, Dennis E Hruby.   

Abstract

It is well known that viruses, as obligate intracellular parasites, must use their hosts' metabolic machinery in order to replicate their genomes and form infectious progeny virions. What is less well known are the details of how viruses make sure that once all the necessary proteins are made, that they assume the correct configuration at the proper time in order to catalyse the efficient assembly of infectious virions. One of the methods employed by viruses to regulate this process is the proteolytic cleavage of viral proteins. Over the past several decades, studies in numerous laboratories have demonstrated that morphogenic proteolysis plays a major and essential role during the assembly and maturation of infectious poxvirus virions. In this review we describe the history of vaccinia virus proteolysis as a prototypic viral system. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710840      PMCID: PMC7169229          DOI: 10.1002/rmv.499

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  72 in total

1.  Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components.

Authors:  Camilo Ansarah-Sobrinho; Bernard Moss
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Studies on the structural proteins of vaccinia virus. I. Structural proteins of virions and cores.

Authors:  J A Holowczak; W K Joklik
Journal:  Virology       Date:  1967-12       Impact factor: 3.616

3.  Characterization of ts 16, a temperature-sensitive mutant of vaccinia virus.

Authors:  M Ericsson; S Cudmore; S Shuman; R C Condit; G Griffiths; J K Locker
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Biogenesis of vaccina: interrelationship between post-translational cleavage, virus assembly, and maturation.

Authors:  M Silver; S Dales
Journal:  Virology       Date:  1982-03       Impact factor: 3.616

5.  Immunolocalization of vaccinia virus structural proteins during virion formation.

Authors:  J K Vanslyke; D E Hruby
Journal:  Virology       Date:  1994-02       Impact factor: 3.616

6.  The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo.

Authors:  Marika Hedengren-Olcott; Chelsea M Byrd; Jeffrey Watson; Dennis E Hruby
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  A transcriptionally controlled trans-processing assay: putative identification of a vaccinia virus-encoded proteinase which cleaves precursor protein P25K.

Authors:  S S Whitehead; D E Hruby
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion.

Authors:  H K Choi; L Tong; W Minor; P Dumas; U Boege; M G Rossmann; G Wengler
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

9.  Fatty acid acylation of vaccinia virus proteins.

Authors:  C A Franke; P L Reynolds; D E Hruby
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.

Authors:  L G Payne; K Kristenson
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

View more
  19 in total

1.  A host cell membrane protein, golgin-97, is essential for poxvirus morphogenesis.

Authors:  Dina Alzhanova; Dennis E Hruby
Journal:  Virology       Date:  2007-02-05       Impact factor: 3.616

2.  Activity, specificity, and probe design for the smallpox virus protease K7L.

Authors:  Alexander E Aleshin; Marcin Drag; Naran Gombosuren; Ge Wei; Jowita Mikolajczyk; Arnold C Satterthwait; Alex Y Strongin; Robert C Liddington; Guy S Salvesen
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 3.  Viral infection and human disease--insights from minimotifs.

Authors:  Krishna Kadaveru; Jay Vyas; Martin R Schiller
Journal:  Front Biosci       Date:  2008-05-01

4.  Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Authors:  J Musil; L Kutinova; K Zurkova; P Hainz; K Babiarova; J Krystofova; S Nemeckova
Journal:  Cancer Gene Ther       Date:  2014-02-21       Impact factor: 5.987

5.  The E6 protein from vaccinia virus is required for the formation of immature virions.

Authors:  Olga Boyd; Peter C Turner; Richard W Moyer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

6.  Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive.

Authors:  Olga Boyd; Audra L Strahl; Carson Rodeffer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

7.  Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.

Authors:  Shannon McNulty; William Bornmann; Jill Schriewer; Chas Werner; Scott K Smith; Victoria A Olson; Inger K Damon; R Mark Buller; John Heuser; Daniel Kalman
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

8.  Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth.

Authors:  Matthew A Child; Christian Epp; Hermann Bujard; Michael J Blackman
Journal:  Mol Microbiol       Date:  2010-02-08       Impact factor: 3.501

9.  Isolation and Characterization of Monoclonal Antibodies Against a Virion Core Protein of Orf Virus Strain NA1/11 As Potential Diagnostic Tool for Orf Viruses.

Authors:  Xiaoping Wang; Jiafeng Zhang; Wenbo Hao; Yongzheng Peng; Hong Li; Wei Li; Ming Li; Shuhong Luo
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-08

10.  Biogenesis of the vaccinia virus membrane: genetic and ultrastructural analysis of the contributions of the A14 and A17 proteins.

Authors:  Bethany Unger; Jason Mercer; Kathleen A Boyle; Paula Traktman
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.